blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0170024

EP0170024 - Use of 2-acylaminomethyl-1,4-benzodiazepine derivatives for the production of pharmaceutical compositions and process for the preparation for pharmaceutical compositions [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.05.1990
Database last updated on 19.10.2024
Most recent event   Tooltip07.07.2007Change - inventorpublished on 08.08.2007  [2007/32]
Applicant(s)For all designated states
Merck & Co., Inc.
126, East Lincoln Avenue P.O. Box 2000 Rahway
New Jersey 07065-0900 / US
[N/P]
Former [1986/06]For all designated states
MERCK & CO. INC.
126, East Lincoln Avenue P.O. Box 2000
Rahway New Jersey 07065-0900 / US
Inventor(s)01 / Chang, Raymond S. L.
7 Jonathan Drive
Edison, N.J. 08820 / US
02 / Evans, Ben E.
501 Perkiomen Avenue
Lansdale, PA. 19446 / US
[1986/06]
Representative(s)Blum, Rudolf Emil, et al
E. BLUM & Co. AG Patent- und Markenanwälte VSP Vorderberg 11
8044 Zürich / CH
[N/P]
Former [1986/06]Blum, Rudolf Emil Ernst, et al
c/o E. Blum & Co Patentanwälte Vorderberg 11
CH-8044 Zürich / CH
Application number, filing date85107502.818.06.1985
[1986/06]
Priority number, dateUS1984062484126.06.1984         Original published format: US 624841
[1986/06]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0170024
Date:05.02.1986
Language:EN
[1986/06]
Type: A3 Search report 
No.:EP0170024
Date:31.01.1990
Language:EN
[1990/05]
Search report(s)(Supplementary) European search report - dispatched on:EP14.12.1989
ClassificationIPC:A61K31/55
[1986/06]
CPC:
A61K31/55 (EP); A61P1/00 (EP); A61P25/00 (EP);
A61P43/00 (EP)
Designated contracting statesCH,   DE,   FR,   GB,   IT,   LI,   NL [1986/06]
TitleGerman:Verwendung von 2-Acylaminomethyl-1,4-benzodiazepinderivaten zur Herstellung von pharmazeutischen Zusammensetzungen und Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen[1986/06]
English:Use of 2-acylaminomethyl-1,4-benzodiazepine derivatives for the production of pharmaceutical compositions and process for the preparation for pharmaceutical compositions[1986/06]
French:Utilisation de dérivés de 2-acylaminométhyl-1,4-benzodiazépines pour la préparation de compositions pharmaceutiques et procédé pour la préparation de compositions pharmaceutiques[1986/06]
File destroyed:28.01.1999
Examination procedure31.12.1989Application deemed to be withdrawn, date of legal effect  [1990/25]
26.01.1990Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [1990/25]
Fees paidRenewal fee
26.02.1987Renewal fee patent year 03
28.02.1988Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.06.198905   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:SearchUS4325957  [ ] (ZEUGNER HORST, et al);
 CH611608  [ ] (KALI CHEMIE AG [DE]);
 EP0054839  [ ] (KALI CHEMIE PHARMA GMBH [DE])
    [ ] - GOODMAN and GILMAN'S: "The Pharmacological Basis of Therapeutics", 6th Edition, 1980; MacMillan Publ. Co., New York, USpage 133 "Gastrointestinal Tract".
    [ ] - R. BERKOW: "The Merck Manual of Diagnosis and Therapy", 14th Edition, 1982; MSD Research Laboratories, Rahway, US, pages 790-791"Etiology; Pathophysiology; Treatment".
    [ ] - CHEMICAL ABSTRACTS, Vol. 100, No. 1, January 2, 1984, page 48, Ref. No. 564v; Columbus, Ohio, US, J.E. MORLEY et al.: "The effects of the opioid-benzodiazepine, tifluadom, on ingestive behaviors", & Eur. J. Pharmacol. 1983, 93(3-4), 265-9Abstract.
    [ ] - Life Sciences, Vol. 30, No. 6, 1982, pages 479-493; Pergamon Press, US, J.E. MORLEY: "Minireview; the ascent of cholecystokinin (CCK) - from gut to brain"pages 479,480,483-485.
    [ ] - CHEMICAL ABSTRACTS, Vol. 85, No. 9, August 30, 1976, page 62, Ref. Nr. 56967t; Columbus, Ohio, US, J.H.B. SAUNDERS et al.: "Effect of diazepam and hyoscine butylbromide on response to secretin and cholecystokinin-pancreozymin in man", & Gut 1976, 17(5), 352-3Abstract.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.